MedTrace Logo

Biobank For MS And Other Demyelinating Diseases

NCT00445367 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3226

Last updated 2025-10-02

No results posted yet for this study

Summary

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Conditions

Sponsors & Collaborators

  • Accelerated Cure Project for Multiple Sclerosis

    lead OTHER

Principal Investigators

  • Benjamin Greenberg, M.D., M.H.S. · University of Texas

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2030-10-31
Completion
2036-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00445367 on ClinicalTrials.gov